Catalyst Wire Dossier Catalyst Wire Dossier

Qianweitai (Silodosin Capsule)

silodosin · Shanghai Huilun Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qianweitai (Silodosin Capsule), covering 2025-08-21 to 2025-08-21. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH [Phase 4]

See pricing